Search

Search Constraints

You searched for: Author/Creator Genius, Just

Search Results

3. O4‐11‐02: The path to regulatory qualification of cerebrospinal fluid biomarkers as enrichment tools in clinical trials of patients with early Alzheimer's disease: For the coalition against major diseases. (1st July 2015)

4. Phase 1/1b Studies of UCB0599, an Oral Inhibitor of α‐Synuclein Misfolding, Including a Randomized Study in Parkinson's Disease. Issue 10 (12th August 2022)